CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting
Due to the concern of fratricide, clinical development of CAR T cells for the therapy of T cell malignancies lags behind that for B cell malignancies. Attempts are being made to revise T cell biomarkers so that the re-engineered CAR T cells can target T cell malignancies. CD3 and CD7 are the two pan...
Saved in:
Published in | Journal of hematology & oncology Vol. 16; no. 1; p. 18 |
---|---|
Main Authors | , , |
Format | Journal Article Conference Proceeding |
Language | English |
Published |
England
BioMed Central Ltd
05.03.2023
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!